glp-1 ibd GLPs as novel therapeutic options in IBD-potential mechanisms of action The alleviating effect and mechanism

Our Strongest Conviction Call: Eli Lilly Headed 21% Higher in 12 Months

Gastrointestinal tract is an important connector between food intake and body weight, it senses basic tastes in a similar manner as the tongue

World Obesity Federation, World Obesity Atlas 2023 Unsurprisingly, weight loss medications have captured innovators attention as potential solutions, however, the obesity market has a history of many false dawns, as drugs in the past failed to deliver meaningful efficacy while some had serious safety issues, e.g., Fen-Phen, which was eventually withdrawn from the market due to cardiac risks3

In addition, WHO included GLP-1 therapies on its Essential Medicines List (EML)

Together they work as a powerful duo